These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34667676)

  • 1. A Rare Case of Rapid Onset Thrombocytopenia Induced by Piperacillin/Tazobactam in a Liver Transplant Recipient.
    Al-Sardi M; Ali H; Handoo F; AlJawad M
    Cureus; 2021 Sep; 13(9):e18000. PubMed ID: 34667676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Beaulieu C; Kurczewski L; Yajnik V
    J Thromb Thrombolysis; 2019 Jul; 48(1):167-170. PubMed ID: 30968302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin-Tazobactam Induced Rapid Severe Thrombocytopenia Without Known Exposure.
    Bhaskarla A; Gorecki MD; Ghouse M
    Cureus; 2022 Jul; 14(7):e26970. PubMed ID: 35989762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage.
    Lv J; Wu G; Zhang F; Su X
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e91-e94. PubMed ID: 33558219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.
    Wang Q; He Z; Wu X; Wei Y; Huang J
    Int J Clin Pharm; 2020 Aug; 42(4):1026-1035. PubMed ID: 32500262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of probable piperacillin/tazobactam-induced bone marrow suppression in a pregnant woman.
    ElSalem S; Elawad S; Ahmed A; AlSaadi M; AlHail M
    Eur J Hosp Pharm; 2019 May; 26(3):170-172. PubMed ID: 31428326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid-onset piperacillin-tazobactam induced thrombocytopenia.
    Shaik S; Kazi HA; Ender PT
    J Pharm Pract; 2015 Apr; 28(2):204-6. PubMed ID: 25609660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.
    Paterson DL; Muto CA; Ndirangu M; Linden PK; Potoski BA; Capitano B; Bonomo RA; Aron DC; Donskey CJ
    Antimicrob Agents Chemother; 2008 Feb; 52(2):465-9. PubMed ID: 18025111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP; Kramer CJ; Bartel BJ; Catlin JS; Gilder RE
    Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
    Clemmons AB; Bech CF; Pantin J; Ahmad I
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin/Tazobactam: Evaluation of Its In vitro Activity against Bacteria Isolated in Two Brazilian Hospitals and an Overview of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Potential.
    Sader HS; Ferreira AT; Tosin I; Gales AC; Keim LS; Carbadillo JM; Mello SJ; Tavares W
    Braz J Infect Dis; 1998 Oct; 2(5):241-255. PubMed ID: 11103015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam-induced neurotoxicity in a hemodialysis patient: a case report.
    Neves PD; Freitas FM; Kojima CA; Carmello BL; Bazan R; Barretti P; Martin LC
    Hemodial Int; 2015 Jan; 19(1):143-5. PubMed ID: 25098503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK; Pettit RS
    Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin-induced Thrombocytopenia in a Dual Heart and Kidney Transplant Patient: A Case Report.
    Patel S; Levin-Epstein R; Kobashigawa J
    Transplant Proc; 2017 Sep; 49(7):1672-1674. PubMed ID: 28784558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing
    Benanti GE; Brown ART; Shigle TL; Tarrand JJ; Bhatti MM; McDaneld PM; Shelburne SA; Aitken SL
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.